Compositions and therapeutic methods involving isoflavones and analogues thereof
US7488494B2 · kind B2 · utility
4Cited by
52References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2003 |
| Grant date | Feb 10, 2009 |
| Priority date | — |
| Expiry date | Aug 18, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors. This is exemplified
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.